These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 9298756)
21. Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication. Balzarini J; McGuigan C J Antimicrob Chemother; 2002 Jul; 50(1):5-9. PubMed ID: 12096000 [TBL] [Abstract][Full Text] [Related]
22. Antiviral activity of oxetanocins against varicella-zoster virus. Sakuma T; Saijo M; Suzutani T; Yoshida I; Saito S; Kitagawa M; Hasegawa S; Azuma M Antimicrob Agents Chemother; 1991 Jul; 35(7):1512-4. PubMed ID: 1656865 [TBL] [Abstract][Full Text] [Related]
23. Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase. Sienaert R; Andrei G; Snoeck R; De Clercq E; McGuigan C; Balzarini J Biochem Biophys Res Commun; 2004 Mar; 315(4):877-83. PubMed ID: 14985094 [TBL] [Abstract][Full Text] [Related]
25. Identification of an indol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor. Musella S; di Sarno V; Ciaglia T; Sala M; Spensiero A; Scala MC; Ostacolo C; Andrei G; Balzarini J; Snoeck R; Novellino E; Campiglia P; Bertamino A; Gomez-Monterrey IM Eur J Med Chem; 2016 Nov; 124():773-781. PubMed ID: 27639368 [TBL] [Abstract][Full Text] [Related]
26. 6-azapyrimidine-2'-deoxy-4'-thionucleosides: antiviral agents against TK+ and TK- HSV and VZV strains. Maslen HL; Hughes D; Hursthouse M; De Clercq E; Balzarini J; Simons C J Med Chem; 2004 Oct; 47(22):5482-91. PubMed ID: 15481985 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of 5-substituted derivatives of the potent antiherpes agent (north)-methanocarbathymine. Russ P; Schelling P; Scapozza L; Folkers G; Clercq ED; Marquez VE J Med Chem; 2003 Nov; 46(23):5045-54. PubMed ID: 14584954 [TBL] [Abstract][Full Text] [Related]
28. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs. Andrei G; Topalis D; Fiten P; McGuigan C; Balzarini J; Opdenakker G; Snoeck R J Virol; 2012 Mar; 86(5):2641-52. PubMed ID: 22190713 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and antiviral activity of novel 5-(1-cyanamido-2-haloethyl) and 5-(1-hydroxy(or methoxy)-2-azidoethyl) analogues of uracil nucleosides. Kumar R; Rai D; Sharma SK; Saffran HA; Blush R; Tyrrell DL J Med Chem; 2001 Oct; 44(21):3531-8. PubMed ID: 11585457 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of novel phosphoramidate ProTides of the 2'-fluoro derivatives of a potent anti-varicella zoster virus bicyclic nucleoside analogue. Derudas M; Quintiliani M; Brancale A; Andrei G; Snoeck R; Balzarini J; McGuigan C Antivir Chem Chemother; 2010 Oct; 21(1):15-31. PubMed ID: 21045257 [TBL] [Abstract][Full Text] [Related]
31. Susceptibility of protein kinase (ORF47)-deficient varicella-zoster virus strains to anti-herpesvirus nucleosides. Suzutani T; Ogasawara M; Shibaki T; Azuma M Antiviral Res; 2000 Jan; 45(1):79-82. PubMed ID: 10774592 [TBL] [Abstract][Full Text] [Related]
32. Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines. Reefschläger J; Herrmann G; Bärwolff D; Schwarz B; Cech D; Langen P Antiviral Res; 1983 Sep; 3(3):175-87. PubMed ID: 6316849 [TBL] [Abstract][Full Text] [Related]
33. Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV. Bevilacqua F; Davis-Poynter N; Worrallo J; Gower D; Collins P; Darby G J Gen Virol; 1995 Aug; 76 ( Pt 8)():1927-35. PubMed ID: 7636473 [TBL] [Abstract][Full Text] [Related]
34. 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus. Averett DR; Koszalka GW; Fyfe JA; Roberts GB; Purifoy DJ; Krenitsky TA Antimicrob Agents Chemother; 1991 May; 35(5):851-7. PubMed ID: 1649571 [TBL] [Abstract][Full Text] [Related]
35. Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation of anti-VZV agents. Snoeck R; Schols D; Sadzot-Delvaux C; Cloes JM; Andrei G; De Clercq E; Piette J; Rentier B J Virol Methods; 1992 Aug; 38(2):243-54. PubMed ID: 1325472 [TBL] [Abstract][Full Text] [Related]
36. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS. Talarico CL; Phelps WC; Biron KK J Virol; 1993 Feb; 67(2):1024-33. PubMed ID: 8380452 [TBL] [Abstract][Full Text] [Related]
37. Anti-herpesvirus activity profile of 4'-thioarabinofuranosyl purine and uracil nucleosides and activity of 1-beta-D-2'-fluoro-4'-thioarabinofuranosyl guanine and 2,6-diaminopurine against clinical isolates of human cytomegalovirus. Machida H; Ashida N; Miura S; Endo M; Yamada K; Kitano K; Yoshimura Y; Sakata S; Ijichi O; Eizuru Y Antiviral Res; 1998 Aug; 39(2):129-37. PubMed ID: 9806489 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compounds. Slusarchyk WA; Bisacchi GS; Field AK; Hockstein DR; Jacobs GA; McGeever-Rubin B; Tino JA; Tuomari AV; Yamanaka GA; Young MG J Med Chem; 1992 May; 35(10):1799-806. PubMed ID: 1316966 [TBL] [Abstract][Full Text] [Related]
39. The cytostatic activity of 5-(1-azidovinyl)-2'-deoxyuridine (AzVDU) against herpes simplex virus thymidine kinase gene-transfected FM3A cells is due to inhibition of thymidylate synthase and enhanced by UV light (lambda = 254 nm) exposure. Balzarini J; Andrei G; Kumar R; Knaus EE; Wiebe LI; De Clercq E FEBS Lett; 1995 Oct; 373(1):41-4. PubMed ID: 7589430 [TBL] [Abstract][Full Text] [Related]
40. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations. Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]